ZOTEFOAMS PLC — Director's Dealing 2017

Apr 10, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1069C

Zotefoams PLC

10 April 2017

Zotefoams plc (the 'Company')

Directors' Shareholdings

On 7 April 2017, the Executive Director listed below became absolutely entitled to Ordinary Shares of 5p ('Shares') each in the capital of the Company, as a result of his award vesting under the Zotefoams 2007 Long-Term Incentive Plan ('LTIP').

Awards granted under the LTIP vest subject to the satisfaction of performance targets at the end of a three year period.  The level of vesting for awards granted in 2014 was 37.7%, which was then increased to reflect the dividends paid during the performance period.

Director	No. of LTIP Shares released to Director	No. of Shares sold to meet tax liability	Sale price (£)	Balance of Shares retained by Director
D B Stirling	34,225	16,119	£3.00	18,106

Following the above-mentioned transaction, which took place on 10 April 2017, Mr Stirling is beneficially interested in the following number of Shares:

Director	Number of Shares¹	Percentage of issued Share Capital
D B Stirling	398,060	0.90

¹ Includes Partnership Shares, Dividend Shares and vested Matching Shares under the Company's Share Incentive Plan.

The Notification of Dealing Form for Mr Stirling can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Enquiries:

James Kindell

Company Secretary

Zotefoams plc

10 April 2017

020 8664 1600

About Zotefoams plc:

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology.  Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide.  Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets.  In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®).

www.zotefoams.com

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

ZOTEFOAMS PLC

DEALING NOTIFICATION FORM

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Stirling

2.

Reason for the notification

a)

Position/status: Group CEO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Vesting of award under the Long-Term Incentive Plan

c)

Price(s) and volume(s):

Price(s)	Volume(s)
£0.00	34,225

d)

Aggregated information:

Aggregate Price	Aggregate Volume	Aggregate Total
£0.00	34,225	£0.00

e)

Date of the transaction: 2017-04-07

f)

Place of the transaction: Outside a trading venue

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Sale of shares that vested under the Long-Term Incentive Plan to pay the tax liability.

c)

Price(s) and volume(s):

Price(s)	Volume(s)
£3.00	16,119

d)

Aggregated information:

Aggregate Price	Aggregate Volume	Aggregate Total
£3.00	16,119	£48,357.00

e)

Date of the transaction: 2017-04-10, 10:55:00

f)

Place of the transaction: XLON

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEASLEFEEXEFF